2 options
Product Patents and Access to Innovative Medicines in a Post-TRIPS era / World Trade Organization.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- World Trade Organization.
- Series:
- WTO Working Papers ; no.2019/05.
- WTO Working Papers ; no.2019/05
- Language:
- English
- Subjects (All):
- Economic research and trade policy analysis.
- Intellectual property.
- Local Subjects:
- Economic research and trade policy analysis.
- Intellectual property.
- Physical Description:
- 48 pages.
- Place of Publication:
- Geneva : World Trade Organization, 2019.
- System Details:
- text file
- Summary:
- This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members- except least-developed country members (LDCs) - to provide pharmaceutical product patents with a 20-year protection term. Developing country members, other than LDCs, were meant to be compliant with this provision of TRIPS by 2005.
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.